Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Krustev, Eugene ^a   Reid, Allison ^a   McDougall, Jason J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CARRAGEENAN; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FATTY ACID AMIDASE; KAOLIN; AMIDASE; BENZAMIDE DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CARBAMIC ACID DERIVATIVE; CYCLOHEXYL CARBAMIC ACID 3'-CARBAMOYLBIPHENYL-3-YL ESTER; ENDOCANNABINOID; FATTY-ACID AMIDE HYDROLASE; INDOLE DERIVATIVE; IODOPRAVADOLINE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ALGESIOMETRY; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD FLOW; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYME INHIBITION; HYPEREMIA; KNEE ARTHRITIS; KNEE PAIN; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; LIMIT OF QUANTITATION; MALE; MEASUREMENT; MOUSE; NONHUMAN; ACUTE DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTHRALGIA; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; HINDLIMB; HYPERALGESIA; INFLAMMATION; KNEE; METABOLISM; PATHOPHYSIOLOGY; SYNOVITIS; WEIGHT BEARING;

ACUTE DISEASE; AMIDOHYDROLASES; ANIMALS; ARTHRALGIA; BENZAMIDES; CARBAMATES; CARRAGEENAN; ENDOCANNABINOIDS; HINDLIMB; HYPERALGESIA; INDOLES; INFLAMMATION; KAOLIN; KNEE JOINT; MALE; MICE, INBRED C57BL; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SYNOVITIS; WEIGHT-BEARING;

EID: 84988851152     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0437-9     Document Type: Article

References (51)

1. Reginster JY: The prevalence and burden of arthritis. Rheumatology (Oxford) 2002, 41:3-6.
2. Khoshbaten A, Ferrell WR: Responses of blood vessels in the rabbit knee to acute joint inflammation. Ann Rheum Dis 1990, 49:540-544.
3. Ley K: Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 1996, 32:733-742.
4. Schaible HG, Schmidt RF: Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J Neurophysiol 1985, 54:1109-1122.
5. Schaible HG, Schmidt RF: Time course of mechanosensitivity changes in articular afferents during a developing experimental arthritis. J Neurophysiol 1988, 60:2180-2195.
6. Heppelmann B, Pawlak M: Sensitisation of articular afferents in normal and inflamed knee joints by substance P in the rat. Neurosci Lett 1997, 223:97-100.
7. Schuelert N, McDougall JJ: Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis. Osteoarthritis Cartilage 2006, 14:1155-1162.
8. McDougall JJ, Pawlak M, Hanesch U, Schmidt RF: Peripheral modulation of rat knee joint afferent mechanosensitivity by nociceptin/orphanin FQ. Neurosci Lett 2000, 288:123-126.
9. Sándor K, Bölcskei K, McDougall JJ, Schuelert N, Reglodi D, Elekes K, Petho G, Pintér E, Szolcsányi J, Helyes Z: Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice. Pain 2009, 141:143-150.
10. Li Z, Proud D, Zhang C, Wiehler S, McDougall JJ: Chronic arthritis downregulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception. Arthritis Rheum 2005, 52:3210-3219.
11. McDougall JJ, Baker CL, Hermann PM: Attenuation of knee joint inflammation by peripherally administered endomorphin-1. J Mol Neurosci 2004, 22:125-137.
12. Russell F, Schülert N, Veldhoen V, McDougall J: Cathepsin G has an anti-nociceptive effect in normal rat knee joints. Inflamm Res 2011, s293-s295.
13. Gaoni Y, Mechoulam R: Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964, 60:1646-1647.
14. Schwarz H, Blanco FJ, Lotz M: Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 1994, 55:107-115.
15. Walker JM, Huang SM, Strangman NM, Tsou K, Sañudo-Peña MC: Pain modulation by release of the endogenous cannabinoid anandamide. Proc Natl Acad Sci U S A 1999, 96:12198-12203.
16. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
17. McDougall JJ: Cannabinoids and pain control in the periphery. In Peripheral receptor targets for analgesia. Edited by Cairns BE. Hoboken, New Jersey: Wiley & Sons Inc; 2009:325-346.
18. Schuelert N, Zhang C, Mogg AJ, Broad LM, Hepburn DL, Nisenbaum ES, Johnson MP, McDougall JJ: Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain. Osteoarthritis Cartilage 2010, 18:1536-1543.
19. Schuelert N, McDougall JJ: Cannabinoid-mediated antinociception is enhanced in rat osteoarthritic knees. Arthritis Rheum 2008, 58:145-153.
20. McDougall JJ, Yu V, Thomson J: In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints. Br J Pharmacol 2008, 153:358-366.
21. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
22. Desarnaud F, Cadas H, Piomelli D: Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem 1995, 270:6030-6035.
23. Bisogno T, De Petrocellis L, Di Marzo V: Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. Curr Pharm Des 2002, 8:533-547.
24. Ahn K, Johnson DS, Mileni M, Beidler D, Long JZ, McKinney MK, Weerapana E, Sadagopan N, Liimatta M, Smith SE, Lazerwith S, Stiff C, Kamtekar S, Bhattacharya K, Zhang Y, Swaney S, Van Becelaere K, Stevens RC, Cravatt BF: Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol 2009, 16:411-420.
25. Schuelert N, Johnson MP, Oskins JL, Jassal K, Chambers MG, McDougall JJ: Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis. Pain 2011, 152:975-981.
26. Andruski B, McCafferty DM, Ignacy T, Millen B, McDougall JJ: Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis. Am J Physiol Regul Integr Comp Physiol 2008, 295:R814-R820.
27. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
28. Kogan NM, Mechoulam R: Cannabinoids in health and disease. Dialogues Clin Neurosci 2007, 9:413-430.
29. Alhouayek M, Lambert DM, Delzenne NM, Cani PD, Muccioli GG: Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J 2011, 25:2711-2721.
30. Murphy N, Cowley TR, Blau CW, Dempsey CN, Noonan J, Gowran A, Tanveer R, Olango WM, Finn DP, Campbell VA, Lynch MA: The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. J Neuroinflammation 2012, 9:79.
31. Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH: Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Pharmacol Biochem Behav 2011, 99:718-725.
32. Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G: Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol 2002, 135:181-187.
33. Cencioni MT, Chiurchiu V, Catanzaro G, Borsellino G, Bernardi G, Battistini L, Maccarrone M: Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One 2010, 5:e8688.
34. Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF: Cannabinoid CB (2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J Cereb Blood Flow Metab 2007, 27:1387-1396.
35. Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF: Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult Scler 2004, 10:158-164.
36. Toguri JT, Lehmann C, Laprairie RB, Szczesniak AM, Zhou J, Denovan-Wright EM, Kelly MEM: Anti-inflammatory effects of cannabinoid CB2 receptor activation in endotoxin-induced uveitis. Br J Pharmacol 2014, 171:1448-1461.
37. Gyombolai P, Boros E, Hunyady L, Turu G: Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor. Mol Cell Endocrinol 2013, 372:116-127.
38. Gauldie SD, McQueen DS, Pertwee R, Chessell IP: Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. Br J Pharmacol 2001, 132:617-621.
39. Gatta L, Piscitelli F, Giordano C, Boccella S, Lichtman A, Maione S, Di Marzo V: Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability. PLoS One 2012, 7:e31111.
40. Ligresti A, Martos J, Wang J, Guida F, Allarà M, Palmieri V, Luongo L, Woodward D, Di Marzo V: Prostamide F(2) a receptor antagonism combined with inhibition of FAAH may block the pro-inflammatory mediators formed following selective FAAH inhibition. Br J Pharmacol 2014, 171:1408-1419.
41. Richardson JD, Kilo S, Hargreaves KM: Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 1998, 75:111-119.
42. Foster CA, Mandak B, Kromer E, Rot A: Calcitonin gene-related peptide is chemotactic for human T lymphocytes. Ann N Y Acad Sci 1992, 657:397-404.
43. McEwan J, Larkin S, Davies G, Chierchia S, Brown M, Stevenson J, MacIntyre I, Maseri A: Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries. Circulation 1986, 74:1243-1247.
44. Xu H, Cheng CL, Chen M, Manivannan A, Cabay L, Pertwee RG, Coutts A, Forrester JV: Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. J Leukoc Biol 2007, 82:532-541.
45. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson N-O, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ: The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007, 152:1092-1101.
46. Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP: The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 2008, 139:225-236.
47. McHugh D, Page J, Dunn E, Bradshaw HB: Δ(9)-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br J Pharmacol 2012, 165:2414-2424.
48. Guindon J, Hohmann AG: The endocannabinoid system and pain. CNS Neurol Disord Drug Targets 2009, 8:403-421.
49. Harris J, Drew LJ, Chapman V: Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. Neuroreport 2000, 11:2817-2819.
50. Lichtman AH, Cook SA, Martin BR: Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J Pharmacol Exp Ther 1996, 276:585-593.
51. Huggins JP, Smart TS, Langman S, Taylor L, Young T: An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Pain 2012, 153:1837-1846.